<DOC>
	<DOCNO>NCT02023671</DOCNO>
	<brief_summary>The study propose SSCVD Allogeneic Stem Cells Hospital provide collection series compose patient multiple myeloma undergo allogeneic stem cell transplant center period 2000-2011 . This collection carry retrospective investigation , review paper electronic record data card already collect part clinical trial conduct Division approve Ethics Committee Management . The purpose data collection particularly retrospective analysis incidence extramedullary relapse , response flow cytometry immunophenotypic clinical response disease , also take consideration overall survival ( OS ) , event-free survival ( EFS ) , cumulative incidence treatment-related mortality graft- versus-host disease ( GVHD ) , acute chronic . The data process completely anonymous provide law . The result study result diagnostic therapeutic intervention patient still alive .</brief_summary>
	<brief_title>IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<criteria>Adult patient multiple myeloma undergo allogeneic stem cell transplantation period 20002011 University Transplant Center Division Hematology . Were take account donor transplant voluntary blood relative . Patients die early allogeneic transplantation ( &lt; 3 month ) evaluate disease status . In evaluation response immunophenotypic disease exclude analysis bone marrow aspirate sample low cellularity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>